ArticleDiscover nano2026
Eco-friendly synthesis and antibacterial evaluation of CuO, ZnO, and CuO-ZnO nanostructures supported by DFT and molecular docking.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant extract-mediated synthesis of metal oxide nanoparticles (MO NPs) offers a sustainable route for biomedical applications due to their biocompatibility and eco-friendly production. In this work, copper oxide (CuO), zinc oxide (ZnO), and novel CuO-ZnO nanocomposites were successfully synthesized using phytochemicals from Pistacia eurycarpa leaves. The nanostructures were comprehensively characterized by XRD, UV-Vis, SEM, EDX, and FTIR analyses, confirming crystalline phases with nanoscale spherical and rod-like morphologies. The optical band gaps (1.6-2.74 eV) indicated suitability for diverse functional applications. The antibacterial activity of the synthesized nanomaterials was evaluated against Escherichia coli and Staphylococcus aureus, revealing significant inhibitory and bactericidal effects. Complementary density functional theory calculations provided insights into their electronic properties, while molecular docking studies demonstrated strong binding interactions with bacterial target proteins Staphylococcus aureus dihydrofolate reductase (2W9H), Escherichia coli DNA gyrase B (6F86) and Estrogen receptor alpha (ERα) (5GS4), supporting their potential bioactivity. Overall, this combined experimental and computational study highlights the promising antibacterial potential of green-synthesized CuO, ZnO, and CuO-ZnO nanostructures and underscores their applicability as eco-friendly agents for biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.